CN104473173B - 预防中老年心血管疾病的保健食品及其制备方法 - Google Patents
预防中老年心血管疾病的保健食品及其制备方法 Download PDFInfo
- Publication number
- CN104473173B CN104473173B CN201510000267.5A CN201510000267A CN104473173B CN 104473173 B CN104473173 B CN 104473173B CN 201510000267 A CN201510000267 A CN 201510000267A CN 104473173 B CN104473173 B CN 104473173B
- Authority
- CN
- China
- Prior art keywords
- parts
- health food
- blood
- garlic
- angiocardiopathy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 235000013402 health food Nutrition 0.000 title abstract description 22
- 239000000052 vinegar Substances 0.000 claims abstract description 19
- 235000021419 vinegar Nutrition 0.000 claims abstract description 19
- 240000002234 Allium sativum Species 0.000 claims abstract description 17
- 235000004611 garlic Nutrition 0.000 claims abstract description 17
- 230000002265 prevention Effects 0.000 claims abstract description 16
- 244000130270 Fagopyrum tataricum Species 0.000 claims abstract description 15
- 235000014693 Fagopyrum tataricum Nutrition 0.000 claims abstract description 15
- 229920002472 Starch Polymers 0.000 claims abstract description 15
- 235000009754 Vitis X bourquina Nutrition 0.000 claims abstract description 15
- 235000012333 Vitis X labruscana Nutrition 0.000 claims abstract description 15
- 240000006365 Vitis vinifera Species 0.000 claims abstract description 15
- 235000014787 Vitis vinifera Nutrition 0.000 claims abstract description 15
- 239000008107 starch Substances 0.000 claims abstract description 15
- 235000019698 starch Nutrition 0.000 claims abstract description 15
- 244000000626 Daucus carota Species 0.000 claims abstract description 13
- 235000002767 Daucus carota Nutrition 0.000 claims abstract description 13
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 13
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 13
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 13
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 13
- 240000006079 Schisandra chinensis Species 0.000 claims abstract description 13
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims abstract description 13
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims abstract description 13
- 235000021014 blueberries Nutrition 0.000 claims abstract description 13
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 13
- 235000012907 honey Nutrition 0.000 claims abstract description 13
- 239000000843 powder Substances 0.000 claims abstract description 13
- 235000014036 Castanea Nutrition 0.000 claims abstract description 12
- 241001070941 Castanea Species 0.000 claims abstract description 12
- 210000000582 semen Anatomy 0.000 claims abstract description 11
- 240000000851 Vaccinium corymbosum Species 0.000 claims abstract description 10
- 239000000203 mixture Substances 0.000 claims description 13
- 240000007594 Oryza sativa Species 0.000 claims description 7
- 235000007164 Oryza sativa Nutrition 0.000 claims description 7
- 235000009566 rice Nutrition 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000005520 cutting process Methods 0.000 claims description 3
- 235000013312 flour Nutrition 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 3
- 235000012149 noodles Nutrition 0.000 claims description 3
- 235000011837 pasties Nutrition 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 2
- 210000002784 stomach Anatomy 0.000 abstract description 10
- 210000000952 spleen Anatomy 0.000 abstract description 8
- 230000036541 health Effects 0.000 abstract description 6
- 239000000463 material Substances 0.000 abstract description 6
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 5
- 235000013305 food Nutrition 0.000 abstract description 5
- 238000000034 method Methods 0.000 abstract description 5
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 238000005728 strengthening Methods 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 25
- 239000008280 blood Substances 0.000 description 25
- 230000000694 effects Effects 0.000 description 23
- 206010020772 Hypertension Diseases 0.000 description 21
- 235000019197 fats Nutrition 0.000 description 17
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 230000036772 blood pressure Effects 0.000 description 11
- 210000004204 blood vessel Anatomy 0.000 description 11
- 201000010099 disease Diseases 0.000 description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- 210000001367 artery Anatomy 0.000 description 9
- 206010028980 Neoplasm Diseases 0.000 description 8
- 235000012000 cholesterol Nutrition 0.000 description 8
- 208000034189 Sclerosis Diseases 0.000 description 7
- 230000001093 anti-cancer Effects 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 230000003712 anti-aging effect Effects 0.000 description 6
- 230000009286 beneficial effect Effects 0.000 description 6
- 201000011510 cancer Diseases 0.000 description 6
- 208000029078 coronary artery disease Diseases 0.000 description 6
- 230000002526 effect on cardiovascular system Effects 0.000 description 6
- 230000036039 immunity Effects 0.000 description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 208000007536 Thrombosis Diseases 0.000 description 5
- 229930003268 Vitamin C Natural products 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 235000019154 vitamin C Nutrition 0.000 description 5
- 239000011718 vitamin C Substances 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 208000019622 heart disease Diseases 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 208000001953 Hypotension Diseases 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 244000077233 Vaccinium uliginosum Species 0.000 description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000009530 blood pressure measurement Methods 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 208000021822 hypotensive Diseases 0.000 description 3
- 230000001077 hypotensive effect Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 230000004089 microcirculation Effects 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 235000007686 potassium Nutrition 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 239000011691 vitamin B1 Substances 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- 241001280437 Allium unifolium Species 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 241000219051 Fagopyrum Species 0.000 description 2
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- 206010019837 Hepatocellular injury Diseases 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 2
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002213 flavones Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 231100000437 hepatocellular injury Toxicity 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 235000014786 phosphorus Nutrition 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 235000021283 resveratrol Nutrition 0.000 description 2
- 229940016667 resveratrol Drugs 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 206010027439 Metal poisoning Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010030124 Oedema peripheral Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 208000018525 Postpartum Hemorrhage Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 208000020670 canker sore Diseases 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 230000036996 cardiovascular health Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940099352 cholate Drugs 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000015219 food category Nutrition 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 208000008127 lead poisoning Diseases 0.000 description 1
- -1 linoleic acid, leukotrienes Chemical class 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 125000001452 riboflavin group Chemical group 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 210000000515 tooth Anatomy 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 208000005494 xerophthalmia Diseases 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明提供了一种预防心血管疾病的保健食品及其制备方法，该产品所用的材料为：醋蒜、苦荞麦、藕粉、三七粉、松子仁、五味子、熟栗子、蓝莓、葡萄、胡萝卜、蜂蜜，经过合理搭配后制成。本发明的保健食品口感好可以有效预防心血管疾病，此外该产品还有健脾和胃的功能，不仅能使本保健品达到最大化的吸收，还能促进其他食物的吸收。本发明的制备方法工艺简单、生产成本低。
Description
技术领域
本发明涉及一种预防中老年心血管疾病的保健食品及其制备方法。
背景技术
千百年来人们就在寻找能够延年益寿的方法，由于不得法，至今也没有找到一个好方法。其实这些延年益寿的方法就在我们身边，只是人们不会合理的搭配使用，因此收效甚微。心血管疾病是一种常见的中老年疾病，对人类威胁非常大，严重影响延年益寿。
发明内容
本发明的目的是提供一种可以有效预防中老年心血管疾病的保健食品及其制备方法。
本发明的技术方案是：预防中老年心血管疾病的保健食品，按照质量份数包括以下成分：醋蒜45-55份，苦荞麦28-32份，藕粉45-55份，三七粉4-6份，松子仁28-32份，五味子4-6份，熟栗子28-32份，蓝莓45-55份，葡萄45-55份，胡萝卜45-55份，蜂蜜28-32份。
制备本发明预防中老年心血管疾病的保健食品，包括以下步骤：a.将大蒜去外皮并切去根部，用凉开水浸泡12小时，取出后再用温开水冲洗，然后晾干水份，放入无菌大口瓶内，再浇上米醋，浸泡两周后取出晾干，在搅拌机中打成糊状醋蒜。
b.将苦荞麦、松子仁、五味子和熟栗子，洗净晾干，消毒后在搅拌机中打成粉状，过100目筛，形成粉剂。
c.将蓝莓、葡萄、胡萝卜洗净消毒后在搅拌机中打成浆状混合物。
d.将步骤a中的醋蒜、步骤b中的粉剂、步骤c中浆状混合物和藕粉、三七粉放在一起，再加入蜂蜜混合均匀，用熟米粉调好稀稠度，放在平盘中摊成饼状，然后用切刀切成长方块，冷藏保存 。
本发明的有益效果是：醋蒜作为长久的保健食品，它能降血压、降血脂，能预防老年疾病和肿瘤，是天然抗生素，还能杀菌，起到抗生素的作用，它还能使人体中的一种酶保持平衡，避免出现高血压、高血脂，防止冠心病和动脉硬化的过早发生。苦荞麦也能降低“三高”（高血压、高血脂和高血糖），改善心脑血管循环，清除体内垃圾，增强人体免疫力，对糖尿病也有很好的辅助治疗作用，芦丁是它的特有成份，能软化血管，降低血脂，对心血管疾病和高血压都有预防和治疗作用。至于藕粉，能健脾胃，可将胆固醇和甘油三酯排出体外，三七粉更是耳熟能详的止血药，它能扩张血管、溶解血栓以及改善微循环，可预防和治疗高血压、冠心病、心绞痛、脑溢血等病症，同时它还能提高机体免疫力。松子仁能够软化血管及防治动脉硬化，还能降血脂，防止血小板凝固形成血栓。五味子能促进有损细胞再生，防止肝细胞损伤，激活代谢功能，增强DHA合成。栗子含多种微量元素，能预防高血压、冠心病、动脉硬化及骨质疏松，还能抗衰老、延年益寿。蓝莓具有降低胆固醇，防治动脉硬化，促进心血管健康。葡萄中含有白藜芦醇，能防癌，对心脏病和动脉硬化，也十分有益。胡萝卜具有降血压、降血糖及抗癌等多种功能，所含的维生素A、维生素C是心血管的保护神。蜂蜜在此起到调和众药的作用，其所含有的矿物质、微量元素及多种酶，不仅能延年益寿，还可治多种疾病，早晨空腹一杯蜂蜜水，对高血压、肝脏病、心脏病都有一定的疗效。以上所述物质各有各的特点，但他们共同都对心血管有益，对他们的合理搭配即可起到对心血管的保护作用。某些物质还能抗癌防癌，减少这两大疾病对人类的威胁，增加人们的寿命，起到延年益寿的作用。
具体实施方式
实施例1
本发明预防中老年心血管疾病的保健食品，其按质量份数含有以下成分：
醋蒜50份，苦荞麦30份，藕粉50份，三七粉5份，松子仁25份，五味子5份，熟栗子30份，蓝莓50份，葡萄50份，胡萝卜50份，蜂蜜30份。
制备本发明预防中老年心血管疾病的保健食品，包括以下步骤：a.将大蒜去外皮并切去根部，用凉开水浸泡12小时，取出后再用温开水冲洗，然后晾干水份，放入无菌大口瓶内，再浇上米醋，浸泡两周后取出晾干，在搅拌机中打成糊状醋蒜。
b.将苦荞麦、松子仁、五味子和熟栗子，洗净晾干，消毒后在搅拌机中打成粉状，过100目筛，形成粉剂。
c.将蓝莓、葡萄、胡萝卜洗净消毒后在搅拌机中打成浆状混合物。
d.将步骤a中的醋蒜、步骤b中的粉剂、步骤c中浆状混合物和藕粉、三七粉放在一起，再加入蜂蜜混合均匀，用熟米粉调好稀稠度，放在平盘中摊成饼状，然后用切刀切成1厘米厚，1.5厘米宽，2.5厘米长的长方块，冷藏保存。
实施例2
本发明预防中老年心血管疾病的保健食品，其按质量份数含有以下成分：
醋蒜45份，苦荞麦32份，藕粉50份，三七粉6份，松子仁25份，五味子4份，熟栗子28份，蓝莓48份，葡萄55份，胡萝卜50份，蜂蜜28份。
制备方法同实施例1，不再赘述。
实施例3
本发明预防中老年心血管疾病的保健食品，其按质量份数含有以下成分：
醋蒜55份，苦荞麦28份，藕粉45份，三七粉4份，松子仁32份，五味子6份，熟栗子30份，蓝莓45份，葡萄45份，胡萝卜55份，蜂蜜32份。
制备方法同实施例1，不再赘述。
实施例4
本发明预防中老年心血管疾病的保健食品，其按质量份数含有以下成分：
醋蒜50份，苦荞麦28份，藕粉45份，三七粉6份，松子仁28份，五味子4份，熟栗子32份，蓝莓45份，葡萄50份，胡萝卜45份，蜂蜜30份。
制备方法同实施例1，不再赘述。
以上实施例只是较优选择，本发明并局限于实施例。食用者可根据自己的口感和身体需要作适当调整，但含糖成份的物质不宜过多。每天坚持食用两次，即可起到预防老年人心血管疾病的目的。
各种材料的技术性能与功效：
（1）醋蒜
醋蒜能够止咳平喘，解毒散瘀，降血压，降血脂，预防老年性疾病和肿瘤，是天然的抗生素，能杀菌，是人体循环及神经系统的天然强健剂，能抗癌，治疗阳痿，抗衰老，抗疲劳，具有保护心血管的功效。每天两至三瓣能降血压，保持体内一种酶的适当数量，避免出现高血压。对于降低血脂、软化血管、预防冠心病及动脉硬化有明显作用，可防止血栓形成。能预防衰老，有效预防铅中毒，但不能多吃过多对眼不利影响维生素B的吸收。
（2）苦荞麦
苦荞麦能软化血管，改善微循环，清热解毒，活血化瘀，拔毒生肌，对病灶起到缓解和屏障作用，能降“三高”，抗氧化，增张人体的免疫力，改善心脑循环，消除体内垃圾。所含有的苦荞黄酮，对糖尿病有辅助治疗作用，含有的苦荞碱黄酮能抗心律失常，增加冠状动脉流量，保护心肌缺血，降血脂，所含总碱能防止白细胞减低和抗辐射，对多种菌和真菌有抑制作用，苦荞麦含多种脂肪和多种维生素、氨基酸，所含芦丁是苦荞麦的特有成份，能软化血管，降低血脂，对心血管病及高血压有较好的预防治疗作用，能控制血糖，治疗糖尿病，有健脾化滞清热的功效。
（3）藕粉
藕粉能够清热凉血，健脾开胃，能与人体中的胆酸盐、食物中胆固醇及甘油酸酯结合并排出体外，所含鞣质能促进食欲，促消化，有益于胃纳不佳，食欲不振者恢复健康，含有铁、钙等微量元素，还含有植物蛋白、维生素、淀粉等，能补益气血，增强人体免疫力，能补养精神，益气力，止血散瘀生肌，益脾健胃，养血补益。
（4）三七粉
三七粉可治外伤出血，也可治疗淤血、胃出血、尿血等各种内出血症。能扩张血管，溶解血栓，改善微循环，预防和治疗高血压、胆固醇、冠心病、心绞痛、脑溢血后遗症等心血管疾病，对脂肪肝、肝纤维化、产后出血、久病等原因引起的体虚症均有疗效，能够活血通脉，补血补气，提高免疫力，对降“三高”也有一定作用。
（5）松子仁
松子仁具有味甘性温，滋阴润肺，美容抗衰老及延年益寿等功效，也可用于干燥咳嗽、慢性便秘等症。所含亚油酸、亚麻酸能够软化血管，防治动脉硬化，防止因胆固醇引起的心血管疾病，含有丰富的磷，有益大脑，对慢性支气管炎、支气管哮喘、风湿性关节炎及神经衰弱等均有辅助治疗作用，含维生素E能抗氧化、抗衰老，具有预防心血管疾病的作用。能降低血脂、软化血管、防止动脉硬化，有防止血小板凝固的作用，因此能降血脂、降血凝，防止血栓形成。
（6）五味子
五味子能促进肝胃的解毒作用，促进受损细胞再造，消炎，防止肝细胞损伤，激活代谢，促进受损细胞修复，增加DHA合成，促进受损细胞活性，增强人体免疫力和对疾病的抗拒力。
（7）栗子
益气补脾，健胃厚肠，能帮助脂肪代谢，健身壮骨，消除疲劳，含有淀粉、脂肪、蛋白质和B族维生素B1、B2，营养丰富，含多种微量元素钾、镁、铁、锌、锰等，钾含量高。含有丰富的不饱和脂肪酸和矿物质，能防高血压、冠心病、动脉硬化、骨质疏松、抗衰老并延年益寿。含有核黄素，对口舌生疮及口腔溃疡有益，能帮助脂肪代谢，具有益气健脾，厚补肠胃的功效。含有维生素C，能维持牙齿、骨骼、血管、肌肉的正常功能，可预防骨质疏松、腰腿酸痛及筋骨疼痛。
（8）蓝莓
蓝莓可有效降低胆固醇，防止动脉硬化，促进心血管健康，含有花青贰色素，具有活化视网膜的功效，强化视力，防眼球疲劳，含有维生素C，有强心功能，还能预防癌症和心脏病的功效，预防脑神经衰老，改善伤风、感冒及咽喉肿痛。
（9）葡萄
葡萄具有防癌功效：含有抗癌元素白藜芦醇，能防止健康细胞变成癌细胞，阻止癌细胞扩散。具有护心功能：含黄酮类物质，对面部缺血性心脏病和动脉粥样硬化性心脏病有益；黄酮类物质能抗癌防癌，能清洗血管，阻断胆固醇斑块形成。具有护肝功能：葡萄中含有葡萄糖及多种维生素和纤维素，对保护肝脏、减轻腹水和下肢浮肿的效果非常明显,还能提高血浆白蛋白,降低转氨酶；葡萄中的果酸还能帮助消化、增加食欲，防止肝炎后脂肪肝的发生。
（10）胡萝卜
胡萝卜含胡萝卜素、维生素B1、维生素B2、维生素C、维生素D、维生素E、叶酸和食物纤维，胡萝卜素能形成维生素A，改善视觉，防止眼睛和皮肤干燥，胡萝卜素等多种营养物质能明目养容、降血糖、降血压以及抗肺癌等多种功效，尤其适合癌症、高血压、夜盲症、干眼症，含有的维生素A和维生素C是心血管的保护神，胶质和矿物质能降低胆固醇，能缓解因压力大造成的不良情绪，还有提神醒脑的作用。
（11）蜂蜜
大脑中所需要的能量在蜂蜜中含量最高，所含果糖及葡萄糖可很快被吸收，能够改善血液营养，含有人体血清浓度相近的无机盐，含有维生素B1、维生素B2、维生素B6、铁、钙、铜、锰、磷、钾以及淀粉酶、脂肪酶和转化酶，是食物中含酶最多的物质，酶可助消化，是一系列物质代谢及化学变化的促进物，他不仅有滋补作用，还是治病的良药，可治胃炎，早空腹饮一杯蜂蜜水，对高血压、肝脏病及心脏病都有一定的疗效。
本发明的保健品属于食品范畴，无须疗效实验，从原料功效的法定和公认性，可以认定产品的功效。但为了进一步了解本发明的功效，我们对食用者食用后的效果进行了追踪了解，以下是一些典型案例：
典型案例1
张某，男，55岁，患高血压多年，属于轻度高血压，每日坚持早晚各饮食上述实施例1中的保健食品15g-20g，食用5天后血压测量显示明显下降，继续坚持每天服用，2个星期后，测量血压恢复正常 ，目前，每天坚持吃至少1次。
典型案例2
杨某，女，65岁，患高血压多年，属于中度高血压，需要长期服用降压药，每日坚持早晚各饮食上述实施例2中的保健食品15g-25g，食用3天后血压测量显示明显下降，继续坚持每天服用，15天后，测量血压在轻度高血压范围内，配合减剂量降压药可将血压控制在正常范围内。连续服用30天保健食品，停止服用降压药，测量血压恢复正常。目前，每天坚持吃至少服用20g保健品。
典型案例3
李某，男，59岁，患高血脂多年，每日坚持早晚各饮食上述实施例3中的保健食品15g-20g，1个月后检查，血脂的相关指数得到下降。
典型案例4
李某，男，45岁，患高血脂多年，同时有脾胃虚寒症状，每日坚持早晚各饮食上述实施例4中的保健食品25g，1个月后检查，血脂的相关指数得到下降，脾胃虚寒症状明显缓解。
典型案例5
程某，女，63岁，患高血压多年，属于重度高血压，需要长期服用降压药且血压经常反复升高，每日坚持早晚各饮食上述实施例3中的保健食品20g-30g，食用5天后血压测量显示明显下降，继续坚持每天服用，15天后，测量血压在中度高血压范围内，配合降压药可将血压控制在正常范围内。在食用过程中连续服用30天后，配合减剂量降压药，血压在正常范围内，血压未出现反复升高现象。目前，每天坚持吃至少服用30g保健品。
从上述案例中可以看出，本发明的预防中老年心血管疾病的保健食品对高血压、高血脂有一定的疗效，对于症状轻微者坚持服用后可以治疗，对于重度病症者需要服用药物，不能完全代替药物治疗，但本品对高血压、高血脂控制有促进作用。本发明预防中老年心血管疾病的保健食品由多种具有特殊功效的成分组成，其功效并不局限于上述典型案例，上述案例只是本发明一些功效的体现。
Claims (1)
1.一种制备预防中老年心血管疾病的组合物的制备方法，其特征在于，所述组合物由按照质量份数的以下原料制成：醋蒜45-55份，苦荞麦28-32份，藕粉45-55份，三七粉4-6份，松子仁28-32份，五味子4-6份，熟栗子28-32份，蓝莓45-55份，葡萄45-55份，胡萝卜45-55份，蜂蜜28-32份，经以下步骤制备而成，a.将大蒜去外皮并切去根部，用凉开水浸泡12小时，取出后再用温开水冲洗，然后晾干水份，放入无菌大口瓶内，再浇上米醋，浸泡两周后取出晾干，在搅拌机中打成糊状醋蒜；b.将苦荞麦、松子仁、五味子和熟栗子，洗净晾干，消毒后在搅拌机中打成粉状，过100目筛，形成粉剂；c.将蓝莓、葡萄、胡萝卜洗净消毒后在搅拌机中打成浆状混合物；d.将步骤a中的醋蒜、步骤b中的粉剂、步骤c中浆状混合物和藕粉、三七粉放在一起，再加入蜂蜜混合均匀，用熟米粉调好稀稠度，放在平盘中摊成饼状，然后用切刀切成长方块，冷藏保存。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510000267.5A CN104473173B (zh) | 2015-01-04 | 2015-01-04 | 预防中老年心血管疾病的保健食品及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510000267.5A CN104473173B (zh) | 2015-01-04 | 2015-01-04 | 预防中老年心血管疾病的保健食品及其制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104473173A CN104473173A (zh) | 2015-04-01 |
| CN104473173B true CN104473173B (zh) | 2017-09-15 |
Family
ID=52747894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510000267.5A Active CN104473173B (zh) | 2015-01-04 | 2015-01-04 | 预防中老年心血管疾病的保健食品及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104473173B (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105795424A (zh) * | 2016-03-29 | 2016-07-27 | 闭献灿 | 一种辅助降血脂的制品及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1386436A (zh) * | 2002-06-12 | 2002-12-25 | 刘长雁 | 一种醋蒜调料 |
| CN101627806B (zh) * | 2009-07-27 | 2011-06-22 | 刘洪涛 | 一种养生粥 |
| CN102090637A (zh) * | 2009-12-09 | 2011-06-15 | 严悦铭 | 一种含有胶原蛋白的复方营养粉 |
| JP2013075874A (ja) * | 2011-09-30 | 2013-04-25 | Sunstar Inc | 血糖代謝改善剤 |
-
2015
- 2015-01-04 CN CN201510000267.5A patent/CN104473173B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN104473173A (zh) | 2015-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101090284B1 (ko) | 홍삼과 녹용 추출물을 포함하는 드링크제 및 그의 제조방법 | |
| CN104872504A (zh) | 一种替代日常饮食且营养均衡的代餐粉及其制备方法 | |
| CN105285952A (zh) | 一种营养均衡的代餐粉及其制备方法 | |
| CN107259571A (zh) | 一种代餐食物及其制备方法 | |
| CN102224891B (zh) | 一种糖醇蜂蜜苹果酱及其制备方法 | |
| CN102599568B (zh) | 一种代酒饮料及其制备方法 | |
| US20090004168A1 (en) | Health Enhancement System | |
| CN106858215A (zh) | 一种百香果复合饮料 | |
| CN105918387A (zh) | 一种适用中老年保健食品及制备方法 | |
| Kandasamy et al. | Medicinal and nutritional characteristics of fruits in human health | |
| CN104473173B (zh) | 预防中老年心血管疾病的保健食品及其制备方法 | |
| CN109730222A (zh) | 酵素复合液及其保健饮料 | |
| KR102131341B1 (ko) | 탈모 예방, 발모 촉진, 및 두피 개선 효과가 우수한 건강 선식 제조 방법 | |
| KR101391713B1 (ko) | 샐러드 드레싱 조성물 | |
| CN114748583A (zh) | 一种滋补养生的中药药酒 | |
| CN111743141A (zh) | 一种小米辣酱及其制备方法 | |
| CN105265911A (zh) | 一种蛹虫草调味品及其制备方法 | |
| Arya | Food is your Medicine | |
| RU2792449C2 (ru) | Состав фиточая, содержащего биологически активные добавки | |
| CN107029129A (zh) | 一种内服外涂结合治疗爱滋病、肿瘤的药剂 | |
| CN111728187A (zh) | 一种银鱼酱及其制备方法 | |
| Gautam et al. | The nutritive and health benefits of fresh raw fruits VS fruit juices | |
| CN115708853A (zh) | 一种治疗关节性疼痛液及其制备方法 | |
| McKeith | Dr. Gillian McKeith's Living Food for Health: 12 Natural Superfoods to Transform Your Health | |
| CN114847482A (zh) | 一种防治风湿药膳产品及其加工方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB03 | Change of inventor or designer information |
Inventor after: Yao Yunlong Inventor after: Ma Guangying Inventor after: Yao Xueming Inventor before: Yao Yunlong Inventor before: Ma Guangying Inventor before: Yao Xueming Inventor before: Liu Luyan Inventor before: Shi Tingting Inventor before: Tan Guangren Inventor before: Zhang Ming Inventor before: Yuan Linghua Inventor before: Zheng Benguang |
|
| COR | Change of bibliographic data | ||
| CB03 | Change of inventor or designer information | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zhang Biao Inventor before: Yao Yunlong Inventor before: Ma Guangying Inventor before: Yao Xueming |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20170516 Address after: Qingpu District Xujing town Huqingping 201799 Shanghai City No. 2008 10 floor room 1025 Applicant after: SHANGHAI NUODING BIOTECHNOLOGY CO.,LTD. Address before: 264209 Weihai Cultural Road West, Shandong, No. 180 Applicant before: SHANDONG University WEIHAI |
|
| TA01 | Transfer of patent application right | ||
| CB03 | Change of inventor or designer information | ||
| CB03 | Change of inventor or designer information |
Inventor after: Yao Yunlong Inventor after: Ma Guangying Inventor after: Yao Xueming Inventor before: Zhang Biao |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20170525 Address after: 264209 Weihai Cultural Road West, Shandong, No. 180 Applicant after: SHANDONG University WEIHAI Address before: Qingpu District Xujing town Huqingping 201799 Shanghai City No. 2008 10 floor room 1025 Applicant before: SHANGHAI NUODING BIOTECHNOLOGY CO.,LTD. |
|
| TA01 | Transfer of patent application right | ||
| CB03 | Change of inventor or designer information |
Inventor after: Wang Yehuang Inventor after: Wang Yangguang Inventor after: Wang Yunan Inventor after: Li Xiaolan Inventor after: Li Yuxiang Inventor before: Yao Yunlong Inventor before: Ma Guangying Inventor before: Yao Xueming |
|
| TA01 | Transfer of patent application right | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20170809 Address after: 264200, Shandong Weihai economic and Technological Development Zone Qilu Road No. 68 technical quality control department Applicant after: WEIHAI YUSHANFANG BIOLOGICAL TECHNOLOGY Co.,Ltd. Address before: 264209 Weihai Cultural Road West, Shandong, No. 180 Applicant before: SHANDONG University WEIHAI |
|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20231109 Address after: No. 1580, Chengda Road, Weihai Economic and Technological Development Zone, Shandong 264205 Patentee after: Weihai Unisplendour Youjian Technology Co.,Ltd. Address before: 264200 technology and quality control department, 68 Qilu Avenue, Weihai Economic and Technological Development Zone, Shandong Province Patentee before: WEIHAI YUSHANFANG BIOLOGICAL TECHNOLOGY Co.,Ltd. |